Amoy Diagnostics Co.,Ltd.’s Net Profit Rose 10.6% in 2022

Amoy Diagnostics Co.,Ltd. (厦门艾德生物医药科技股份有限公司) (300685.SZ) reported a net profit of 264.3 million yuan in 2022, up 10.6% year-on-year.

Meanwhile, the company posted 842.2 million yuan in revenue, down 8.2% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 151.2 million yuan in total liabilities, with a liability-to-asset ratio of 9.2%.